A randomized, placebo-controlled, double-blind study to evaluate safety and dose dependent clinical efficacy of APO-2 at three different doses in patients with diabetic foot ulcer (MARSYAS II)

  • Enzelsberger, Klaus (Researcher)
  • Ettinger, Monika (Researcher)
  • Fischer, Tobias (Researcher)
  • Mayr, Elisabeth (Researcher)
  • Hötzenecker, Wolfram (PI)

Project: Clinical studiesClinical Study (Industry project)

Project Details

StatusFinished
Effective start/end date01.01.202001.01.2023

Fields of science

  • 302087 Venereology
  • 302011 Dermatology